Skip to main content

Table 1 Baseline characteristics of POSEIDON Group 4 patients with AOA or non-AOA

From: Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles

Parameters

AOA

(n = 91)

Non-AOA

(n = 168)

P value

Age (years)

40.9 ± 2.8

40.4 ± 2.7

0.138

Body mass index (kg/m2)

23.1 ± 3.8

23.4 ± 3.5

0.540

Infertility duration (years)

5.0 ± 3.5

4.6 ± 3.7

0.478

Previous IVF attempts (%)

  

0.009

 0

20.9%(19/91)

39.3%(66/168)

 

 1 ~ 2

42.9%(39/91)

35.7%(60/168)

 

3

36.3%(33/91)

25.0%(42/168)

 

Types of infertility (%)

  

0.033

 Primary infertility

62.6%(57/91)

48.8%(82/168)

 

 Secondary infertility

37.4%(32/91)

51.2%(86/168)

 

Basal FSH (IU/l)

8.5 ± 9.3

5.4 ± 3.8

0.003

Antral follicle counts (n)

6.3 ± 3.0

6.9 ± 3.6

0.156

Anti-Müllerian hormone (ng/mL)

0.57 ± 0.32

0.67 ± 0.32

0.028

  1. Data are presented as the mean ± standard deviation and %
  2. AOA Artificial oocyte activation, IVF In vitro fertilization, FSH Follicle-stimulating hormone